
Bogdan Popescu MD
Hematologic Oncology, Clinical Pharmacology
Physician
Join to View Full Profile
513 Parnassus Avenue Room HSE 713San Francisco, CA 94143
Dr. Popescu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Carol Davila University of Medicine and PharmacyClass of 2015
Certifications & Licensure
- NJ State Medical License 2018 - 2027
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia.Bogdan Popescu, Matthew F Jones, Madison Piao, Elaine Tran, Andrew Koh
Biorxiv. 2025-06-14 - 2 citationsDNA Sequencing of CD138 Cell Population Reveals TP53 and RAS-MAPK Mutations in Multiple Myeloma at Diagnosis.Mihaela Dragomir, Onda-Tabita Călugăru, Bogdan Popescu, Cerasela Jardan, Dumitru Jardan
Cancers. 2024-01-14 - 4 citationsAllosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML.Bogdan Popescu, Carlos Stahlhut, Theodore C Tarver, Sydney Wishner, Bianca J Lee
Cell Reports. Medicine. 2023-11-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: